Options volume is relatively light, with 35k contracts traded and calls leading puts for a put/call ratio of 0.77, compared to a typical level near 0.72. Implied volatility (IV30) dropped 0.76 to 29.77, in the highest 10% of observations over the past year, suggesting an expected daily move of $0.42. Put-call skew flattened, suggesting a modestly bullish tone.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Pfizer’s Hold Rating: Balancing Policy Uncertainties and Long-Term Growth Prospects
- U.S. biotech companies debate relocating trials outside U.S., Reuters reports
- Terns Pharmaceuticals price target lowered to $15 from $26 at BMO Capital
- Trump’s drug-price crackdown may lead to minor concessions, WSJ reports
- Pharma Stocks Rally despite Trump’s Plan to Cut Drug Prices